Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009:2009:126917.
doi: 10.1155/2009/126917. Epub 2008 Dec 25.

Characterization of a novel polymorphism in PPARG regulatory region associated with type 2 diabetes and diabetic retinopathy in Italy

Affiliations

Characterization of a novel polymorphism in PPARG regulatory region associated with type 2 diabetes and diabetic retinopathy in Italy

Valerio Costa et al. J Biomed Biotechnol. 2009.

Abstract

Peroxisome proliferator-activated receptor gamma polymorphisms have been widely associated with type 2 diabetes, although their role in the pathogenesis of vascular complications is not yet demonstrated. In this study, a cohort of 211 type 2 diabetes, 205 obese, and 254 control individuals was genotyped for Pro12Ala, C1431T, C-2821T polymorphisms, and for a newly identified polymorphism (A-2819G). The above-mentioned polymorphisms were analyzed by gene-specific PCR and direct sequencing of all samples. A significant difference was found for -2819G frequency when patients with type 2 diabetes-particularly diabetic women with the proliferative retinopathy-were compared with healthy control individuals. In conclusion, we identified a novel polymorphism, A-2819G, in PPARG gene, and we found it to be associated with type 2 diabetes and proliferative retinopathy in diabetic females. In the analyzed population, this variant represents a genetic risk factor for developing the diabetic retinopathy, whereas Pro12Ala and C1431T do not.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Comparison of A-2819G frequencies in diabetic women with background or proliferative retinopathy and control women.

References

    1. Francis GA, Fayard E, Picard F, Auwerx J. Nuclear receptors and the control of metabolism. Annual Review of Physiology. 2003;65:261–311. - PubMed
    1. Mukherjee R, Jow L, Croston GE, Paterniti JR., Jr. Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARγ2 versus PPARγ1 and activation with retinoid X receptor agonists and antagonists. The Journal of Biological Chemistry. 1997;272(12):8071–8076. - PubMed
    1. Sabatino L, Casamassimi A, Peluso G, et al. A novel peroxisome proliferator-activated receptor γ isoform with dominant negative activity generated by alternative splicing. The Journal of Biological Chemistry. 2005;280(28):26517–26525. - PubMed
    1. Rosen ED, Spiegelman BM. PPARγ: a nuclear regulator of metabolism, differentiation, and cell growth. The Journal of Biological Chemistry. 2001;276(41):37731–37734. - PubMed
    1. Hasstedt SJ, Ren Q-F, Teng K, Elbein SC. Effect of the peroxisome proliferator-activated receptor-γ2 Pro12Ala variant on obesity, glucose homeostasis, and blood pressure in members of familial type 2 diabetic kindreds. The Journal of Clinical Endocrinology & Metabolism. 2001;86(2):536–541. - PubMed

Publication types